nucleic acids detection
Recently Published Documents


TOTAL DOCUMENTS

37
(FIVE YEARS 11)

H-INDEX

10
(FIVE YEARS 1)

Nano Today ◽  
2021 ◽  
Vol 41 ◽  
pp. 101308
Author(s):  
Na Li ◽  
Yuee Zhao ◽  
Yu Liu ◽  
Zhe Yin ◽  
Rui Liu ◽  
...  

2021 ◽  
Vol 27 (S1) ◽  
pp. 1696-1698
Author(s):  
Roman Novikov ◽  
Julia Kacher ◽  
Anna Gribkova ◽  
Petr Zaytsev ◽  
Grigoriy Armeev ◽  
...  

PROTEOMICS ◽  
2021 ◽  
pp. 2100046
Author(s):  
Tudor Luchian ◽  
Loredana Mereuta ◽  
Yoonkyung Park ◽  
Alina Asandei ◽  
Irina Schiopu

Talanta ◽  
2021 ◽  
Vol 225 ◽  
pp. 121991
Author(s):  
Guoliang Zheng ◽  
Jiangshan Dai ◽  
Haiyan Wang ◽  
Ling Li ◽  
Deyu Yuan ◽  
...  

Methods ◽  
2021 ◽  
Author(s):  
Ross Ka-Kit Leung ◽  
Qiu-Xiang Cheng ◽  
Zhi-Le Wu ◽  
Gulfaraz Khan ◽  
Yang Liu ◽  
...  

NANO ◽  
2020 ◽  
Author(s):  
Zhikun Zhang ◽  
Wenmeng Zhao ◽  
Cuixia Hu ◽  
Yapeng Cao ◽  
Jimmy Yun ◽  
...  

2020 ◽  
Vol 1695 ◽  
pp. 012060
Author(s):  
P Afonicheva ◽  
A Zubik ◽  
A Bulyanitsa ◽  
G Rudnitskaya ◽  
A Evstrapov

PLoS ONE ◽  
2020 ◽  
Vol 15 (10) ◽  
pp. e0240536
Author(s):  
Eduardo Nogueira Cunha ◽  
Maria Fernanda Bezerra de Souza ◽  
Daniel Carlos Ferreira Lanza ◽  
João Paulo Matos Santos Lima

Author(s):  
George Papadakis ◽  
Alexandros K. Pantazis ◽  
Nikolaos Fikas ◽  
Stella Chatziioannidou ◽  
Kleita Michaelidou ◽  
...  

AbstractMost methods applied to nucleic acids’ detection at the point-of-care require either expensive and mostly bench-top instruments or simpler inexpensive systems providing qualitative results. Truly decentralized approaches to reliable, quantitative and affordable diagnostics are still missing. Here, we report the development of real-time quantitative colorimetric LAMP based on a portable and cost-effective device, the use of which requires minimal training. Main advantages of the method are the rapid analysis time (<30min); quantification over a large dynamic range (9 log units); ability to work with crude samples (saliva, tissue); demonstrated low detection limit (1-10 copies); smartphone-operation and fast prototyping (3D-printing). The system’s broad detection capability is demonstrated during infectious diseases-testing for COVID-19 and pharmacogenetics for BRAF V600E mutation testing. Validation studies showed 97.4% and 100% agreement with qRT-PCR for SARS-CoV-2 RNA detection extracted from positive and negative patients’ samples (89), respectively; and 100% agreement with ddPCR and Sanger sequencing for BRAF V600E mutation detection from 12 clinical biopsy samples. The new methodology provides a needed solution for affordable healthcare at the point-of-care, with emphasis on global diagnostics.


Sign in / Sign up

Export Citation Format

Share Document